--- title: Recent Updates to USP <795> and <797> description: United States Pharmacopeia (USP) has recently issued revisions to both USP <797>and <795>. image: https://info.consortiex.com/hubfs/U.S.-Pharmacopeia-USP.png --- [![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png "ConsortiEX")](https://www.consortiex.com) - [Home](https://consortiex.com/) - Solutions - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/) - [Assure-Trak® | Health System](https://consortiex.com/health-system/) - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/) - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/) - [ConsortiEX Blog](https://info.consortiex.com/blog) - More - [About ConsortiEX](https://www.consortiex.com/about-consortiex/) - [Meet the Team](https://www.consortiex.com/meet-our-team/) - [Resources](https://info.consortiex.com/resources) - [DSCSA Resources](https://consortiex.com/dscsa-resources/) - Contact - [Current Customer Support](https://consortiex.com/support/) - [Request a Demo](https://consortiex.com/contact-us/) - [Home](https://consortiex.com/) - Solutions - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/) - [Assure-Trak® | Health System](https://consortiex.com/health-system/) - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/) - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/) - [ConsortiEX Blog](https://info.consortiex.com/blog) - More - [About ConsortiEX](https://www.consortiex.com/about-consortiex/) - [Meet the Team](https://www.consortiex.com/meet-our-team/) - [Resources](https://info.consortiex.com/resources) - [DSCSA Resources](https://consortiex.com/dscsa-resources/) - Contact - [Current Customer Support](https://consortiex.com/support/) - [Request a Demo](https://consortiex.com/contact-us/) November 4, 2021 # Recent Updates to USP <795> and <797> ![U.S.-Pharmacopeia-USP](https://info.consortiex.com/hs-fs/hubfs/U.S.-Pharmacopeia-USP.png?width=600&name=U.S.-Pharmacopeia-USP.png)   *Update: USP is hosting an open forum on revisions to both USP <795> (Jan 12) and <797> (Jan 19). Follow this link to register: [https://www.usp.org/events-training/virtual-open-forum-series-proposed-revisions-to-compounding-general-chapters](https://www.usp.org/events-training/virtual-open-forum-series-proposed-revisions-to-compounding-general-chapters) * Nov. 4, 2021 - MILWAUKEE United States Pharmacopeia (USP) has recently issued revisions to both USP <797> Pharmaceutical Compounding—Sterile Preparations, and USP <795> Pharmaceutical Compounding—Non-Sterile Preparations. Compounding is a crucial component of patient care, granting access to medications for patients who are unable to use commercially available formulations due to dosing requirements, allergies or rare disease. Meeting requirements set forth by USP can minimize the risk of adverse events or death in patients who use compounded medication. Find high-level overviews of revised topics or inclusions below. Click [here](https://go.usp.org/l/323321/2021-08-31/5kmjww/323321/16304645801icecobH/797_PHARMACEUTICAL_COMPOUNDING_STERILE_PREPARATIONS_POST_Revised.pdf) for the full USP <797> Guidance, or [here](https://go.usp.org/l/323321/2021-08-31/5kmjwt/323321/1630464575pHSCnY6w/795_PHARMACEUTICAL_COMPOUNDING_NONSTERILE_PREPARATIONS_POST_Revised.pdf) for the full USP <795> Guidance.   Notable Topics of Revision in USP <797> 1 - Expanded guidance for assigning Beyond-Use-Date (BUD) for Compounded Sterile Preparations (CSPs) - Guidance for assigning BUDs to compounded multiple-dose containers, including information on assigning BUDs for non-preserved ophthalmic CSPs - Update terminology and rename CSP Microbial Risk Levels - Set a maximum batch size of 250 final yield units for all CSPs that require sterility testing - Add guidance on the use and storage of entered or punctured conventionally manufactured products - Add requirements for maintaining master formulation and compounding records - Add guidance on use of isolators - Remove specific information related to the handling of hazardous drugs and add cross-references to Hazardous Drugs—Handling in Healthcare Settings ⟨800⟩ - Remove specific information related to radiopharmaceuticals as CSPs and add cross-references to Radiopharmaceuticals—Preparation, Compounding, Dispensing, and Repackaging ⟨825⟩. Notable Topics of Revision in USP <795> 2 - Expand guidance for assigning BUDs for compounded non-sterile preparations (CNSPs) in the absence of stability information. - Elaborate on the role of water activity in determining BUD limits for preparations. - Add a table of commonly compounded dosage forms and their respective water activity levels to aid compounders in determining BUD limits for CNSPs - Clarify the requirements for identifying the need for a recall and related procedures.   Stay tuned to the ConsortiEX Blog for compliance updates and recommendations. As always, if you have any concerns about your compliance or internal practices, [let’s talk](https://consortiex.com/contact-us/)! 1 - [*https://go.usp.org/l/323321/2021-08-31/5kmjww/323321/16304645801icecobH/797\_PHARMACEUTICAL\_COMPOUNDING\_STERILE\_PREPARATIONS\_POST\_Revised.pdf*](https://go.usp.org/l/323321/2021-08-31/5kmjww/323321/16304645801icecobH/797_PHARMACEUTICAL_COMPOUNDING_STERILE_PREPARATIONS_POST_Revised.pdf) 2 - [*https://go.usp.org/l/323321/2021-08-31/5kmjwt/323321/1630464575pHSCnY6w/795\_PHARMACEUTICAL\_COMPOUNDING\_NONSTERILE\_PREPARATIONS\_POST\_Revised.pdf*](https://go.usp.org/l/323321/2021-08-31/5kmjwt/323321/1630464575pHSCnY6w/795_PHARMACEUTICAL_COMPOUNDING_NONSTERILE_PREPARATIONS_POST_Revised.pdf) [FDA Provides new Guidance to 503A Compounding Facilities](https://info.consortiex.com/blog/fda-provides-new-guidance-to-503a-compounding-facilities) [ConsortiEX, Inc. and ANiGENT Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-inc.-and-anigent-announce-strategic-partnership) ### Related Posts ## [ConsortiEX Customer Spotlight | Cape Cod Healthcare](https://info.consortiex.com/blog/consortiex-customer-spotlight-cape-cod-healthcare) ## [ConsortiEX | ASHP Midyear 2023](https://info.consortiex.com/blog/consortiex-ashp-midyear-2023) ## [Customer Spotlight | Indiana University Health (ISC)](https://info.consortiex.com/blog/customer-spotlight-indiana-university-health-isc) ### Recent Posts - [In Response to the FDA Announcement](https://info.consortiex.com/blog/in-response-to-the-fda) October 11, 2024 - [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights) August 6, 2024 - [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership) March 13, 2024 ### Topics - [ConsortiEX (22)](https://info.consortiex.com/blog/tag/consortiex) - [DSCSA (21)](https://info.consortiex.com/blog/tag/dscsa) - [DQSA (18)](https://info.consortiex.com/blog/tag/dqsa) - [FDA (18)](https://info.consortiex.com/blog/tag/fda) - [Compounding (17)](https://info.consortiex.com/blog/tag/compounding) - [batch compounding (16)](https://info.consortiex.com/blog/tag/batch-compounding) - [drug quality and security act (16)](https://info.consortiex.com/blog/tag/drug-quality-and-security-act) - [patient safety (16)](https://info.consortiex.com/blog/tag/patient-safety) - [assure-trak (15)](https://info.consortiex.com/blog/tag/assure-trak) - [Blog (14)](https://info.consortiex.com/blog/tag/blog) - [Track and Trace (13)](https://info.consortiex.com/blog/tag/track-and-trace) - [Drug Supply Chain Security Act (12)](https://info.consortiex.com/blog/tag/drug-supply-chain-security-act) - [IV workflow software (12)](https://info.consortiex.com/blog/tag/iv-workflow-software) - [Industry (12)](https://info.consortiex.com/blog/tag/industry) - [Pharmacy IT software (11)](https://info.consortiex.com/blog/tag/pharmacy-it-software) - [health care pharmacy (11)](https://info.consortiex.com/blog/tag/health-care-pharmacy) - [iv workflow (11)](https://info.consortiex.com/blog/tag/iv-workflow) - [503B (10)](https://info.consortiex.com/blog/tag/503b) - [503A (9)](https://info.consortiex.com/blog/tag/503a) - [compliance (9)](https://info.consortiex.com/blog/tag/compliance) - [iv workflow management (9)](https://info.consortiex.com/blog/tag/iv-workflow-management) - [Total Ingredient Life Cycle (8)](https://info.consortiex.com/blog/tag/total-ingredient-life-cycle) - [enterprise resource planning (8)](https://info.consortiex.com/blog/tag/enterprise-resource-planning) - [pedigree to patient (8)](https://info.consortiex.com/blog/tag/pedigree-to-patient) - [pharmacy software (8)](https://info.consortiex.com/blog/tag/pharmacy-software) - [traceability (8)](https://info.consortiex.com/blog/tag/traceability) - [USP (7)](https://info.consortiex.com/blog/tag/usp) - [anticipatory compounding (7)](https://info.consortiex.com/blog/tag/anticipatory-compounding) - [assure-track (6)](https://info.consortiex.com/blog/tag/assure-track) - [pharmaceutical compounding (6)](https://info.consortiex.com/blog/tag/pharmaceutical-compounding) - [Spotlight (5)](https://info.consortiex.com/blog/tag/spotlight) - [compounded sterile preparations (5)](https://info.consortiex.com/blog/tag/compounded-sterile-preparations) - [compounded sterile productions (5)](https://info.consortiex.com/blog/tag/compounded-sterile-productions) - [pharmacy (5)](https://info.consortiex.com/blog/tag/pharmacy) - [pharmacy it (5)](https://info.consortiex.com/blog/tag/pharmacy-it) - [quality assurance (5)](https://info.consortiex.com/blog/tag/quality-assurance) - [DSCSA Compliance (4)](https://info.consortiex.com/blog/tag/dscsa-compliance) - [EDI (4)](https://info.consortiex.com/blog/tag/edi) - [News (4)](https://info.consortiex.com/blog/tag/news) - [T3 Documentation (4)](https://info.consortiex.com/blog/tag/t3-documentation) - [USP 797 (4)](https://info.consortiex.com/blog/tag/usp-797) - [clean room (4)](https://info.consortiex.com/blog/tag/clean-room) - [compounded IV bags (4)](https://info.consortiex.com/blog/tag/compounded-iv-bags) - [compounded syringe (4)](https://info.consortiex.com/blog/tag/compounded-syringe) - [drug serialization (4)](https://info.consortiex.com/blog/tag/drug-serialization) - [order management (4)](https://info.consortiex.com/blog/tag/order-management) - [sterile product compounding (4)](https://info.consortiex.com/blog/tag/sterile-product-compounding) - [transaction history transaction information transa (4)](https://info.consortiex.com/blog/tag/transaction-history-transaction-information-transa) - [DQSA - USP 797 (3)](https://info.consortiex.com/blog/tag/dqsa-usp-797) - [DSCSA CaaS (3)](https://info.consortiex.com/blog/tag/dscsa-caas) - [DSCSA Software (3)](https://info.consortiex.com/blog/tag/dscsa-software) - [Drug Counterfeiting (3)](https://info.consortiex.com/blog/tag/drug-counterfeiting) - [EPCIS (3)](https://info.consortiex.com/blog/tag/epcis) - [Requirements (3)](https://info.consortiex.com/blog/tag/requirements) - [drug borrow loan (3)](https://info.consortiex.com/blog/tag/drug-borrow-loan) - [dscsa compliance as a service 3T (3)](https://info.consortiex.com/blog/tag/dscsa-compliance-as-a-service-3t) - [exchange (3)](https://info.consortiex.com/blog/tag/exchange) - [guidance (3)](https://info.consortiex.com/blog/tag/guidance) - [illegitimate product (3)](https://info.consortiex.com/blog/tag/illegitimate-product) - [pharmacy erp (3)](https://info.consortiex.com/blog/tag/pharmacy-erp) - [suspect product (3)](https://info.consortiex.com/blog/tag/suspect-product) - [3Ts (2)](https://info.consortiex.com/blog/tag/3ts) - [ASHP (2)](https://info.consortiex.com/blog/tag/ashp) - [COVID-19 (2)](https://info.consortiex.com/blog/tag/covid-19) - [Compliance as a Service (2)](https://info.consortiex.com/blog/tag/compliance-as-a-service) - [Compounding Pharmacy (2)](https://info.consortiex.com/blog/tag/compounding-pharmacy) - [DSCSA service (2)](https://info.consortiex.com/blog/tag/dscsa-service) - [DSCSA software and service (2)](https://info.consortiex.com/blog/tag/dscsa-software-and-service) - [Data Entry (2)](https://info.consortiex.com/blog/tag/data-entry) - [Drug supply chain transparency (2)](https://info.consortiex.com/blog/tag/drug-supply-chain-transparency) - [Electronic Data Interchange (2)](https://info.consortiex.com/blog/tag/electronic-data-interchange) - [Environmental monitoring (2)](https://info.consortiex.com/blog/tag/environmental-monitoring) - [Manual T3 Conversion (2)](https://info.consortiex.com/blog/tag/manual-t3-conversion) - [NDC tracking (2)](https://info.consortiex.com/blog/tag/ndc-tracking) - [Passive auditing (2)](https://info.consortiex.com/blog/tag/passive-auditing) - [Prescription tracking (2)](https://info.consortiex.com/blog/tag/prescription-tracking) - [T3 (2)](https://info.consortiex.com/blog/tag/t3) - [T3 Conversion (2)](https://info.consortiex.com/blog/tag/t3-conversion) - [T3s (2)](https://info.consortiex.com/blog/tag/t3s) - [compounded IV bag (2)](https://info.consortiex.com/blog/tag/compounded-iv-bag) - [compounded syringes (2)](https://info.consortiex.com/blog/tag/compounded-syringes) - [drug supply chain (2)](https://info.consortiex.com/blog/tag/drug-supply-chain) - [drug transfers (2)](https://info.consortiex.com/blog/tag/drug-transfers) - [dscsa deadline (2)](https://info.consortiex.com/blog/tag/dscsa-deadline) - [fda guidance (2)](https://info.consortiex.com/blog/tag/fda-guidance) - [patient specific compounding (2)](https://info.consortiex.com/blog/tag/patient-specific-compounding) - [pharmacy serialization (2)](https://info.consortiex.com/blog/tag/pharmacy-serialization) - [pharmacy supply chain (2)](https://info.consortiex.com/blog/tag/pharmacy-supply-chain) - [product (2)](https://info.consortiex.com/blog/tag/product) - [product identifier (2)](https://info.consortiex.com/blog/tag/product-identifier) - [quarantine (2)](https://info.consortiex.com/blog/tag/quarantine) - [regulation (2)](https://info.consortiex.com/blog/tag/regulation) - [serialization (2)](https://info.consortiex.com/blog/tag/serialization) - [sterile injectable compound (2)](https://info.consortiex.com/blog/tag/sterile-injectable-compound) - [vaccine (2)](https://info.consortiex.com/blog/tag/vaccine) - [503B. outsourcing facility (1)](https://info.consortiex.com/blog/tag/503b-outsourcing-facility) - [Bar Code Medication Verification (1)](https://info.consortiex.com/blog/tag/bar-code-medication-verification) - [Central Sterile Compounding (1)](https://info.consortiex.com/blog/tag/central-sterile-compounding) - [Cleanroom (1)](https://info.consortiex.com/blog/tag/cleanroom) - [Compounding Quality Act (1)](https://info.consortiex.com/blog/tag/compounding-quality-act) - [ISMP (1)](https://info.consortiex.com/blog/tag/ismp) - [Pharmacy Informatics (1)](https://info.consortiex.com/blog/tag/pharmacy-informatics) - [Technology Assisted IV Workflow Software (1)](https://info.consortiex.com/blog/tag/technology-assisted-iv-workflow-software) - [USP . USP 800 (1)](https://info.consortiex.com/blog/tag/usp-usp-800) - [audit (1)](https://info.consortiex.com/blog/tag/audit) - [barcode (1)](https://info.consortiex.com/blog/tag/barcode) - [central-fill (1)](https://info.consortiex.com/blog/tag/central-fill) - [community involvement (1)](https://info.consortiex.com/blog/tag/community-involvement) - [compounding management system (1)](https://info.consortiex.com/blog/tag/compounding-management-system) - [deadline (1)](https://info.consortiex.com/blog/tag/deadline) - [draft guidance (1)](https://info.consortiex.com/blog/tag/draft-guidance) - [drug loan borrow (1)](https://info.consortiex.com/blog/tag/drug-loan-borrow) - [drug waste (1)](https://info.consortiex.com/blog/tag/drug-waste) - [dynamic patient specific (1)](https://info.consortiex.com/blog/tag/dynamic-patient-specific) - [grandfathered (1)](https://info.consortiex.com/blog/tag/grandfathered) - [grandfathered product (1)](https://info.consortiex.com/blog/tag/grandfathered-product) - [software (1)](https://info.consortiex.com/blog/tag/software) - [specialty compounding (1)](https://info.consortiex.com/blog/tag/specialty-compounding) - [verification systems (1)](https://info.consortiex.com/blog/tag/verification-systems) See all [![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)](http://acc-dev.consortiex.com/) - - *733 N Van Buren St, Ste 501* *Milwaukee, WI 53202* *Office: (414) 231-4575* *Support: (888) 434-1442* *Email: info@consortiex.com* - [Homepage](https://www.consortiex.com/) - [About ConsortiEX](https://www.consortiex.com/about-consortiex/) - [Blog](https://info.consortiex.com/blog) - [Contact Us](https://www.consortiex.com/contact-us/) - [DSCSA Compliance](https://www.consortiex.com/dscsa-compliance/) - [Health System](https://www.consortiex.com/health-system/) - [Magnifier™ Analytics](https://consortiex.com/consortiex-magnifier-analytics/) - [Outsourcing Facility 503B](https://www.consortiex.com/outsourcing-facility-503b/) - [Resources](https://info.consortiex.com/resources) 2025 | ConsortiEX Inc. | All Rights Reserved